Autopsy report · NCT01465919

Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C

Cause of deathSlow enrollment Automatic label, confidence 0.5, unverified. How labels are made.

“Due to the recent change in standard of care for hepatitis C.”

The sponsor’s own words in the registry.

Life of this trial

Registered 3 months after it had already started.
Ran for about 6 years 7 months before it stopped.
5 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 4
Sponsor: Seoul National University Boramae Hospital
Sponsor type: University, hospital or other
Conditions: Depression
Interventions: Mirtazapine; Supportive psychotherapy
Participants: 5
Sites: 1
Countries: South Korea

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.